Neuromuscular blockers in Brazil;O uso de bloqueadores neuromusculares no Brasil

Revista Brasileira de Anestesiologia

Volumn 54, Issue 6, 2004, Pages 850-864

  Simões De Almeida, Maria Cristina ^a,b,c  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^c NONE   (Brazil)

Author keywords

Neuromuscular blockers

Indexed keywords

ATRACURIUM; CISATRACURIUM; GALLAMINE; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; RAPACURONIUM BROMIDE; ROCURONIUM; SUXAMETHONIUM; VECURONIUM;

ANESTHESIA INDUCTION; ANESTHESIST; APNEA; ARTICLE; BRAZIL; BRONCHOSPASM; CHILD; DEATH; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG INDICATION; HEART ARRHYTHMIA; HUMAN; HYPERKALEMIA; MALIGNANT HYPERTHERMIA; MONITOR; NEUROMUSCULAR DISEASE; NEUROMUSCULAR TRANSMISSION; SIDE EFFECT;

EID: 10644284909     PISSN: 00347094     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0034-70942004000600016     Document Type: Article

References (77)

1. Beecher HK, Todd DP - A study of the deaths associated with anesthesia and surgery. Annals of Surgery, 1954;140:2-34.
2. Berg H, Roed J, Viby-Mogensen J et al - Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand, 1997;41:1095-1103.
3. Viby-Mogensen J - Why should I change my practice of anaesthesia: neuromuscular blocking agents. Minerva Anestesiol, 2000;66:273-277.
4. Baillard C, Gehan G, Reboul-Marty J et al - Residual curarization in the recovery room after vecuronium. Br J Anaesth, 2000;84:394-395.
5. Basta SJ, Ali HH, Savarese JJ et al - Clinical pharmacology of atracurium besylate (BW 33A): a new non-depolarizing muscle relaxant. Anesth Analg, 1982;61:723-729.
6. Fisher DM, Canfell PC, Fahey MR et al - Elimination of atracurium in humans: contribution of Hofmann elimination and ester hydrolysis versus organ-based elimination. Anesthesiology, 1986;65:6-12.
7. Cooper RA, Mirakhur RK, Elliott P et al - Estimation of the potency of ORG 9426 using two different modes of nerve stimulation. Can J Anaesth, 1992;39:139-142.
8. Payne JP, Hughes R - Evaluationof atracuriumin anaesthetized man. Br J Anaesth, 1981;53:45-54.
9. Hughes R, Chapple DJ - The pharmacology of atracurium: a new competitive neuromuscular blocking agent. Br J Anaesth, 1981;53:31-44.
10. Moore EW, Hunter JM - The new neuromuscular blocking agents: do they offer any advantages? Br J Anaesth, 2001;87:912-925.
11. Warner DO - Intramuscular succinylcholine and laryngospasm. Anesthesiology, 2001;95:1039-1040.
12. Larson Jr CP - Laryngospasm - the best treatment. Anesthesiology, 1998;89:1293-1294.
13. Kopman AF - Neuromuscular blocking agents: new insights and old controversies. Seminars in Anesthesia, Perioperative Medicine and Pain, 2002;21:75-85.
14. Viby-Mogensen J - Is postoperative residual curarization still a problem? Seminars in Anesthesia, Perioperative Medicine and Pain, 2002;21:130-134.
15. Sullivan M, Thompson WK, Hill GD - Succinylcholine-induced cardiac arrest in children with undiagnosed myopathy. Can J Anaesth, 1994;41:497-501.
16. Haeseler G, Petzold J, Hecker H et al - Succinylcholine metabolite succinic acid alters steady state activation in muscle sodium channels. Anesthesiology, 2000;92:1385-1391.
17. Rosenberg H, Gronert GA - Intractable cardiac arrest in children given succinylcholine. Anesthesiology, 1992;77:1054.
18. Gronert G - Succinylcholine hyperkalemia after burns. Anesthesiology, 1999;91:320-322.
19. Gronert GA - Cardiac arrest after succinylcholine: mortality greater with rhabdomyolysis than receptor upregulation. Anesthesiology, 2001;94:523-529.
20. Goudsouzian NG - Rapacuronium and bronchospasm. Anesthesiology, 2001;94:727-728.
21. Meakin GH, Pronske EH, Lerman J et al - Bronchospasm after rapacuronium in infants and children. Anesthesiology, 2001;94:926-927.
22. White PF - Rapacuronium: why did it fail as a replacement for succinylcholine? Br J Anaesth, 2002;88:163-165.
23. Caldwell JE - Rapid sequence intubation: is rocuronium an alternative? Seminars in Anaesthesia, Perioperative Medicine and Pain, 2002;212:99-103.
24. Meistelman C - Update on neuromuscular pharmacology. Curr Opin Anaesthesiol, 2001;14:399-404.
25. Heier T, Feiner JR, Lin J et al - Hemoglobin desaturation after succinylcholine-induced apnea: astudy of the recovery of spontaneous ventilation in healthy volunteers. Anesthesiology, 2001;94:754-759.
26. Hayes AH, Mirakhur RK, Breslin DS et al - Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anaesthesia, 2001;56:312-318.
27. Fisher DM - Neuromuscular blocking agents in paediatric anaesthesia. Br J Anaesth, 1999;83:58-64.
28. Plaud B, Goujard E, Orliaguet G et al - [Pharmacodynamics and safety of mivacurium in infants and children under halothane-nitrous oxide anesthesia]. Ann Fr Anesth Reanim, 1999;18:1047-1053.
29. Brandom BW, Gavin FF - Neuromuscular clocking drugs in pediatric anesthesia. Anesthesiology Clinics of North America, 2002;30:45-59.
30. Sarner JB, Brandom BW, Woelfel SK - Clinical pharmacology of mivacurium chloride (BW B1090U) in children during nitrous oxide-halothane and nitrous oxide-narcotic anesthesia. Anesth Anaig, 1989;68:116-121.
31. Goudsouzian NG, Alifimoff JK, Eberly C et al - Neuromuscular and cardiovascular effects of mivacurium in children. Anesthesiology, 1989;70:237-242.
32. Miller RD, Rupp SM, Fisher DM et al - Clinical pharmacology of vecuronium and atracurium. Anesthesiology, 1984;61:444-453.
33. Splinter WM, Isaac LA - The pharmacoeconomics of neuromuscular blocking drugs: a perioperative cost-minimization strategy in children. Anesth Analg, 2001;93:339-344.
34. Caldwell JE - The problem with long-acting muscle relaxants? They cost more! Anesth Analg, 1997;85:473-475.
35. Macario A, Vitez TS, Dunn B et al - Where are the costs in perioperative care? Analysis of hospital costs and charges for inpatient surgical care. Anesthesiology, 1995;83:1138-1144.
36. Bevan D - The hidden cost of anesthesia. Can J Anaesth, 2002;49:533-535.
37. Fawcett WJ, Dash A, Francis GA et al - Recovery from neuromuscular blockade: residual curarisation following atracurium or vecuronium by bolus dosing or infusions. Acta Anaesthesiol Scand, 1995;39:288-293.
38. Shorten GD, Merk H, Sieber T - Perioperative train-of-four monitoring and residual curarization. Can J Anaesth, 1995;42:711-715.
39. Brull SJ, Silverman DG - Neuromuscular monitoring and clinical applications: what to do, when, and why? Seminars in Anesthesia, Perioperative Medicine and Pain, 2002;21:104-119.
40. Brand JB, Cullen DJ, Wilson NE et al - Spontaneous recovery from nondepolarizing neuromuscular blockade: correlation between clinical and evoked responses. Anesth Analg, 1977;56:55-58.
41. Ali HH, Wilson RS, Savarese JJ et al - The effect of tubocurarine on indirectly elicited train-of-four muscle response and respiratory measurements in humans. Br J Anaesth, 1975;47:570-574.
42. Kopman AF, Yee PS, Neuman GG - Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology, 1997;86:765-771.
43. Mason LJ, Betts EK - Leg lift and maximum inspiratory force, clinical signs of neuromuscular blockade reversal in neonates and infants. Anesthesiology, 1980;52:441-442.
44. Whittaker M - Plasma cholinesterase variants and the anaesthetist. Anaesthesia, 1980;35:174-197.
45. Goudsouzian NG, d'Hollander AA, Viby-Mogensen J - Prolonged neuromuscular block from mivacurium in two patients with cholinesterase deficiency. Anesth Analg, 1993;77:183-185.
46. Benzer A, Luz G, Oswald E et al - Succinylcholine-induced prolonged apnea in a 3-week-old newborn: treatment with human plasma cholinesterase. Anesth Analg, 1992;74:137-138.
47. Rodriguez-Gonzalez MM, Arribas-Carrion C, Torre-Aznar C et al - Prolonged neuromuscular block with mivacurium. Rev Esp Anestesiol Reanim, 1997;44:328-329.
48. Naguib M, el-Gammal M, Daoud W et al - Human plasma cholinesterase for antagonism of prolonged mivacurium-induced neuromuscular blockade. Anesthesiology, 1995;82:1288-1292.
49. Vanderheyden BA, Reynolds HN, Gerold KB et al - Prolonged paralysis after long-term vecuronium infusion. Crit Care Med, 1992;20:304-307.
50. Partridge BL, Abrams JH, Bazemore C et al - Prolonged neuromuscular blockade after long-term infusion of vecuronium bromide in the intensive care unit. Crit Care Med, 1990;18:1177-1179.
51. Booij LH - The use of muscle relaxants in the intensive care unit. Acta Anaesthesiol Belg, 1997;48:35-44.
52. Sharpe MD - The use of muscle relaxants in the intensive care unit. Can J Anaesth, 1992;39:949-962.
53. Rossiter A, Souney PF, McGowan S et al - Pancuronium-induced prolonged neuromuscular blockade. Crit Care Med, 1991;19:1583-1587.
54. Head-Rapson AG, Devlin JC, Parker CJ et al - Pharmacokinetics of the three isomers of mivacurium and pharmacodynamics of the chiral mixture in hepatic cirrhosis. Br J Anaesth, 1994;73:613-618.
55. Eriksson LI, Lennmarken C, Wyon N et al - Attenuated ventilatory response to hypoxaemia at vecuronium-induced partial neuromuscular block. Acta Anaesthesiol Scand, 1992;36:710-715
56. Pedersen T, Viby-Mogensen J, Ringsted C - Anaesthetic practice and postoperative pulmonary complications. Acta Anaesthesiol Scand, 1992;36:812-818.
57. Watkins J - Investigation of allergic and hypersensitivity reactions to anaesthetic agents. Br J Anaesth, 1987;59:104-111.
58. Watkins J, Wild G, Bex S et al - A case for co-ordinated investigation and reporting of hypersensitivity-type drug reactions in the UK. Anaesthesia, 2000;55:1127-1128.
59. Laxenaire MC - Epidemiology of anesthetic anaphylactoid reactions. Fourth multicenter survey (July 1994-December 1996). Ann Fr Anesth Reanim, 1999;18:796-809.
60. Mertes PM, Laxenaire MC - Allergic reactions occurring during anaesthesia. Eur J Anaesthesiol, 2002;19:240-262.
61. Seed MJ, Ewan PW - Anaphylaxis caused by neostigmine. Anaesthesia, 2000;55:574-575.
62. McNicholas JJ, Harban FM - Anaphylaxis caused by neostigmine. Anaesthesia, 2000;55:1039.
63. Laake JH, Rottingen JA - Rocuronium and anaphylaxis - a statistical challenge. Acta Anaesthesiol Scand, 2001;45:1196-1203.
64. Heier T, Guttormsen AB - Anaphylactic reactions during induction of anaesthesia using rocuronium for muscle relaxation: a report including 3 cases. Acta Anaesthesiol Scand, 2000;44:775-781.
65. Barthelet Y, Ryckwaert Y, Plasse C et al - Severe anaphylactic reactions after administration of rocuronium. Ann Fr Anesth Reanim, 1999;18:896-900.
66. Moss J, Rosow CE - Histamine release by narcotics and muscle relaxants in humans. Anesthesiology, 1983;59:330-339.
67. Watkins J - Adverse reaction to neuromuscular blockers: frequency, investigation, and epidemiology. Acta Anaesthesiol Scand, 1994;102:(Suppl):6-10.
68. Escolano F, Sierra P - Allergic reactions during anesthesia. Rev Esp Anestesiol Reanim, 1996;43:17-26.
69. Naguib M, Magbou M - Adverse effects of neuromuscular blockers and their antagonists. M E J Anesth, 1998;14:341-373.
70. Bevan DR - Neuromuscular blockade. Inadvertent extubation of the partially paralyzed patient. Anesthesiol Clin North America, 2001;19:913-922.
71. Pleym H, Bathen J, Spigset O et al - Ventricular fibrillation related to reversal of the neuromuscular blockade in a patient with long QT syndrome. Acta Anaesthesiol Scand, 1999;43:352-355.
72. Delphin E, Jackson D, Rothstein P - Use of succinylcholine during elective pediatric anesthesia should be reevaluated. Anesth Analg, 1987;66:1190-1192.
73. Bowman WC - Non-relaxant properties of neuromuscular blocking drugs. Br J Anaesth, 1982;54:147-160.
74. Naguib M, Samarkandi AH, Bakhamees HS et al - Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine. Br J Anaesth, 1995;75:588-592.
75. Durant NN, Marshall IG, Savage DS et al - The neuromuscular and autonomic blocking activities of pancuronium, Org NC 45, and other pancuronium analogues, in the cat. J Pharm Pharmacol, 1979;31:831-836.
76. Tassonyi E, Neidhart P, Pittet JF et al - Cardiovascular effects of pipecuronium and pancuronium in patients undergoing coronary artery bypass grafting. Anesthesiology, 1988;69:793-796.
77. Strazis KP, Fox AW - Malignant hyperthermia: a review of published cases. Anesth Analg, 1993;77:297-304.